JACC This Week

Latest Episodes:

Use of Cardiac Rehab in Older Patients with MI Complicated by Cardiogenic Shock | JACC | ACC.25 Mar 24, 2025

Show notes

Dhruv Kazi, MBBS, MS, FACC, and first author Mohammed Essa, MD, discuss their newly published JACC Brief Report presented at ACC.25 on cardiac rehabilitation following myocardial infarction, with a focus on patients who experience cardiogenic shock. JACC: Associate Editor Jason H. Wasfy, MD, MPhil, FACC, asks questions to explore the significant underutilization of cardiac rehab, the impact of social determinants of health, and potential policy changes to improve access and outcomes. Join the conversation as they highlight key findings and the need for innovative solutions in cardiovascular care.

Federal Funding Cuts & Aortic Valve Replacement Outcomes | JACC Baran Mar 18, 2025

Show notes

Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, FACC, and Makoto Mori, MD (Associate Editor) welcome Dr. Tsuyoshi Kaneko, MD, a cardiovascular surgeon, to discuss the impact of federal funding cuts at Columbia University and findings from a large-scale STS database study on bioprosthetic vs. mechanical aortic valve replacement (AVR) in patients aged 40-75 years. Dr. Kaneko provides a surgical perspective on risk-adjusted comparisons, data linkage challenges, and potential biases, while also sharing insights on publishing in JACC and essential writing tips for Japanese researchers.

Can ICD Electrograms help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial | JACC Mar 17, 2025

Show notes

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | JACC Mar 17, 2025

Show notes

Antithrombotic Therapy to Minimize Total Events after ACS or PCI in Atrial Fibrillation: Insights from AUGUSTUS | JACC Mar 17, 2025

Show notes

Biomarker-based model for prediction of ischemic stroke in patients with atrial fibrillation | JACC Mar 17, 2025

Show notes

In CASTLE-HTx Trial We Trust | JACC Mar 17, 2025

Show notes

In the Wake of OCEANIC-AF is Factor XI inhibition Lost at Sea or Still Afloat? | JACC Mar 17, 2025

Show notes

Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials | JACC Mar 17, 2025

Show notes

A New Era in Electrophysiology: Innovation, Integration, and Impact | JACC Mar 17, 2025

Show notes